JENCY NUGIER: Open Payments
NPI 1376274340 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 19 payments from 7 companies in 2025. Trend: 2023 $1,116 · 2024 $1,442 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $135 |
| PFIZER INC. | 4 | $64 |
| Ardelyx, Inc. | 2 | $46 |
| QOL Medical, LLC | 1 | $26 |
| Madrigal Pharmaceuticals | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
Products named: XELJANZ, RINVOQ, IBSRELA, CREON, SKYRIZI, Sucraid, REZDIFFRA, TRULANCE.
Industry payments across LA — which companies pay providers there.
